kynostatin 272 has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, BD; Balis, FM; Farley, MQ; Godwin, K; Jarosinski, P; McCully, CL; Mitsuya, H; Mueller, BU; Murphy, R; Pizzo, PA; Zuckerman, J | 1 |
1 trial(s) available for kynostatin 272 and Disease Models, Animal
Article | Year |
---|---|
Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing.
Topics: Administration, Oral; Adolescent; Animals; Child; Child, Preschool; Disease Models, Animal; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infusions, Intravenous; Macaca mulatta; Male; Oligopeptides | 1998 |